Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cosmos Health Inc COSM

Healthcare
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals... see more

Recent & Breaking News (NDAQ:COSM)

Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens

GlobeNewswire April 8, 2021

Cosmos Holdings Launches Osteodome in EU

GlobeNewswire February 11, 2021

Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement

GlobeNewswire January 11, 2021

Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market

GlobeNewswire December 4, 2020

Cosmos Holdings Begins Trading on the OTCQX® Best Market

GlobeNewswire November 25, 2020

OTC Markets Group Welcomes Cosmos Holdings Inc. to OTCQX

PR Newswire November 25, 2020

Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results

GlobeNewswire November 17, 2020

David Lowenstein Agrees to Join Cosmos Board of Directors

GlobeNewswire November 2, 2020

Cosmos Holdings Engages PGS Ventures to Advise on Strategic Transactions to Accelerate Core Business Expansion

GlobeNewswire October 16, 2020

Cosmos Holdings, Inc. Announces Q2 2020 Financial and Operating Results

GlobeNewswire August 18, 2020

Cosmos Holdings, Inc. Announces Year End 2019 & Q1 2020 Financial and Operating Results

GlobeNewswire May 20, 2020

COSMOS HOLDINGS, INC. SIGNS FOR EXCLUSIVE REPRESENTATION AGREEMENT OF COVID-19 DIAGNOSTIC DETECTION KIT FOR GERMANY, ENGLAND, GREECE & CYPRUS

GlobeNewswire April 8, 2020

Cosmos Holdings Engages Exchange Listing To Assist with its NASDAQ-Listing

GlobeNewswire October 16, 2019

Cosmos Holdings, Inc. Completes $550,000 Debt-to-Equity Conversion at $7.50 Per Share

GlobeNewswire June 25, 2019

Cosmos Holdings, Inc. Completes $500,000 Debt-to-Equity Conversion at $7.50 Per Share

GlobeNewswire May 31, 2019

Cosmos Holdings, Inc. Announces Year End 2018 Financial Results

GlobeNewswire April 23, 2019

Cosmos Holdings, Inc. Adds to Its Advisory Board

GlobeNewswire February 20, 2019

Cosmos Holdings, Inc. Adds Distinguished Portfolio Manager With Mid-Cap & Large-Cap Value Expertise to Its Advisory Board

GlobeNewswire January 11, 2019

UPDATE -- Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.

GlobeNewswire December 21, 2018

Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.

GlobeNewswire December 21, 2018